{"id":"https://openalex.org/W565731983","doi":null,"title":"Examining the influence of the dopamine D2 agonist, cabergoline, on measures of response inhibition and error awareness","display_name":"Examining the influence of the dopamine D2 agonist, cabergoline, on measures of response inhibition and error awareness","publication_year":2011,"publication_date":"2011-10-12","ids":{"openalex":"https://openalex.org/W565731983","mag":"565731983"},"language":"en","primary_location":{"id":"mag:565731983","doi":null,"is_oa":false,"landing_page_url":"https://espace.library.uq.edu.au/view/UQ:275915","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053565384","display_name":"Cassandra Messer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Cassandra Messer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5053565384"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.04496647,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10042","display_name":"Neural and Behavioral Psychology Studies","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10042","display_name":"Neural and Behavioral Psychology Studies","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.46560001373291016,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabergoline","display_name":"cabergoline","score":1.0},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-agonist","display_name":"dopamine D2 receptor agonist","score":0.7889999747276306},{"id":"https://openalex.org/keywords/response-inhibition","display_name":"response inhibition","score":0.9869999885559082},{"id":"https://openalex.org/keywords/error-awareness","display_name":"error awareness","score":0.9980000257492065},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.9010000228881836},{"id":"https://openalex.org/keywords/stop-signal-task","display_name":"stop-signal task","score":0.8069999814033508},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.7960000038146973},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8740000128746033},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.8759999871253967},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":1.0}],"concepts":[{"id":"https://openalex.org/C2779832395","wikidata":"https://www.wikidata.org/wiki/Q423308","display_name":"Cabergoline","level":4,"score":0.9458949565887451},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.845227837562561},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.7755641341209412},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6641198396682739},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6440677046775818},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5592606663703918},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4883594214916229},{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.4452039897441864},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4352949857711792},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.34652596712112427},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.33590376377105713},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.3287646770477295},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.26891517639160156},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.25901156663894653},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23835450410842896},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.230945885181427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22917702794075012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21885082125663757},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.06994253396987915},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.06567004323005676},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:565731983","doi":null,"is_oa":false,"landing_page_url":"https://espace.library.uq.edu.au/view/UQ:275915","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2109637643","https://openalex.org/W2318931314","https://openalex.org/W1188337623","https://openalex.org/W2122538041","https://openalex.org/W2327161802","https://openalex.org/W53408588","https://openalex.org/W3077885689","https://openalex.org/W1969283716","https://openalex.org/W2141858909","https://openalex.org/W7100277822"],"abstract_inverted_index":{"Two":[0],"executive":[1],"functions":[2],"which":[3],"are":[4,12,20],"highly":[5],"important":[6],"to":[7,28,97,113,176,187],"human":[8],"cognition":[9],"and":[10,15,31,35,47,71,83,125,134,171,192,212],"behaviour,":[11],"response":[13,45,123,172,190],"inhibition":[14,46,68,124,173,191],"error":[16,48,126,135,169,193],"awareness.":[17],"Both":[18],"processes":[19],"necessary":[21],"for":[22,33,64,200],"successful":[23],"interactions":[24],"in":[25,66,90,100],"our":[26],"day":[27,29],"lives,":[30],"allow":[32],"flexible":[34],"adaptive":[36],"behaviours.":[37],"Our":[38],"understanding":[39],"of":[40,44,69,73,80,168,203],"the":[41,55,67,85,93,98,116,131,160,201],"pharmacological":[42],"modulation":[43],"awareness":[49,72,136,170,194],"remains":[50],"incomplete.":[51],"Previous":[52],"research":[53],"using":[54,145],"indirect":[56],"dopamine":[57,65,82,101],"agonist":[58],"methylphenidate":[59,77],"has":[60,87,105],"proposed":[61],"a":[62,106,146,177],"role":[63],"responses":[70],"errors.":[74],"However,":[75],"as":[76,128],"increases":[78],"levels":[79],"both":[81,189],"noradrenaline,":[84],"evidence":[86],"been":[88],"inconclusive":[89],"deciding":[91],"whether":[92],"effect":[94],"is":[95,157],"due":[96],"increase":[99,188],"or":[102],"if":[103,115],"noradrenaline":[104],"substantial":[107],"impact.":[108],"The":[109,180],"present":[110],"study":[111],"aimed":[112],"determine":[114],"direct":[117,161],"D2":[118,162],"agonist,":[119,163],"cabergoline,":[120,164],"would":[121],"improve":[122,166],"awareness,":[127],"measured":[129],"by":[130],"stop-signal":[132],"paradigm":[133],"task.":[137],"Twenty-five,":[138],"right":[139],"handed,":[140],"Caucasian":[141],"males":[142],"were":[143,182],"tested":[144],"within-subjects,":[147],"double-blind,":[148],"placebo-controlled":[149],"design.":[150],"In":[151],"line":[152],"with":[153,184],"past":[154],"evidence,":[155],"it":[156],"predicted":[158],"that":[159],"will":[165],"measures":[167],"when":[174],"compared":[175],"placebo":[178],"condition.":[179],"hypotheses":[181],"supported,":[183],"cabergoline":[185],"found":[186],"performance.":[195],"These":[196],"results":[197],"have":[198],"implications":[199],"treatment":[202],"several":[204],"psychiatric":[205],"conditions,":[206],"including;":[207],"attention":[208],"deficit/hyperactivity":[209],"disorder,":[210],"schizophrenia":[211],"obsessive-compulsive":[213],"disorder.":[214]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-12T09:15:50.089291","created_date":"2016-06-24T00:00:00"}